JPAG | Ensuring Amorphous Product Quality: What Are the Challenges?

Schedule a Meeting with CatalentDate: Dec 7, 2017Location: Royal Society of Chemistry, Burlington House, Piccadilly, London W1J 0BAAmorphous drug formulation offers great promise in improving drug solubility - a major challenge in drugdevelopment. However, poor physical stability and hard to predict crystallisation remains key barriers for the...

Schedule a Meeting with Catalent

Date: Dec 7, 2017

Location: Royal Society of Chemistry, Burlington House, Piccadilly, London W1J 0BA

Amorphous drug formulation offers great promise in improving drug solubility - a major challenge in drugdevelopment. However, poor physical stability and hard to predict crystallisation remains key barriers for the wideruse of amorphous solid solution in the pharmaceutical industry. This symposium will critically examine thechallenges and opportunities lie in the analysis of amorphous formulation systems. Leading industrialists andacademics will be sharing their experiences in the development, manufacturing and quality assurance of amorphousproducts. New analytical technologies for the prediction of amorphous stability and novel PAT will be discussed.

Click here to view the event's website.

Catalent Expert Speaking Presentation

Title: “Characterisation approaches to compare different types of amorphous dispersions”
Time: 14:40
Speaker: Dr Krzysztof Sollohub, Senior Spray Drying Scientist, Catalent Pharma Solutions

Source: www.catalent.com